German anti-bribery law threatens current legitimate medtech practices
This article was originally published in Clinica
Executive Summary
The German government is currently in the final stages of deliberating a new draft law aimed at eradicating bribery in the healthcare sector, a law that – once enacted - will create particular challenges for medical device companies.